Enjoy complimentary customisation on priority with our Enterprise License!
Some of the key findings from our gene therapy for inherited genetic disorders market forecast report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders. For instance, LUXTURNA, an AAV-based gene therapy is used for the treatment of biallelic RPE65 mutation associated retinal dystrophy. Similarly, Strimvelis, an ex vivo stem cell gene therapy is indicated as a single treatment for patients with ADA-severe combined immunodeficiency. The high efficacy and safety offered by gene therapy will increase the preference for gene therapy treatments for inherited genetic disorders, subsequently driving gene therapy for inherited genetic disorders market growth during the forecast period.
Additionally, upcoming gene therapy for inherited genetic disorders market trends such as the increase in strategic alliances among vendors will also influence the growth of this global market. Vendors in this market are focusing on entering into partnerships to capitalize on the growing demand for curative gene therapies. Merck KGaA and GenScript Biotech Corp. recently formed an alliance to focus on the manufacturing of plasmid and viral vector in China. Many such alliances among vendors will result in the development of novel gene therapies for patients with inherited genetic disorders. As a result of these factors, the global gene therapy for inherited genetic disorders market size will grow at a CAGR of 189%. However, the market’s momentum will decelerate in the coming years because of the decrease in year-over-year growth.
The global gene therapy for inherited genetic disorders market is highly concentrated. This research report provides a detailed analysis of the market’s competitive landscape and provides information on the products offered by various companies. Key insights provided by this gene therapy for inherited genetic disorders market report will help companies create effective strategies to improve their revenue share.
The report offers a detailed analysis of several leading companies including:
Gene therapy was mainly adopted for the treatment of genetic eye disorders in 2018. With the increasing prevalence of hematological disorders across the world, the adoption of gene therapy will increase in hematological disorders applications and this segment will account for the largest market share by the end of the forecast period.
North America will provide maximum growth opportunities for companies in the gene therapy for inherited genetic disorders market. Vendors in the region are developing drugs for inherited genetic disorders that are in the final stages of clinical trials and are expected to be launched during the forecast period. This coupled with the availability of installment-based reimbursement model will contribute to the growth of gene therapy for inherited genetic disorders market growth in North America.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY APPLICATION
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC SEGMENTATION
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.